• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

完善输血医学的证据基础:英国系统评价倡议的工作

Improving the evidence base for transfusion medicine: the work of the UK systematic review initiative.

作者信息

Brunskill S J, Hyde C J, Stanworth S J, Dorée C J, Roberts D J, Murphy M F

机构信息

NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK.

出版信息

Transfus Med. 2009 Apr;19(2):59-65. doi: 10.1111/j.1365-3148.2009.00910.x. Epub 2009 Mar 23.

DOI:10.1111/j.1365-3148.2009.00910.x
PMID:19320853
Abstract

Clarifying the existing evidence base is crucial to improve the effectiveness of transfusion practice. The UK Systematic Review Initiative has been pursuing this objective primarily through writing systematic reviews on important topics in transfusion medicine. Here, we describe our progress for the past 5 years. We are the only research group that identifies transfusion medicine randomized controlled trials (RCTs) for the Cochrane Central Register of Controlled Trials, and to date, we have contributed 3002 RCT citations. The article considers future challenges including the need for wider involvement from the transfusion medicine community in the process of maintaining and updating systematic reviews and the identification and prioritization of topics for further clinical research including clinical trials. Collaboration between international and local research groups is important if these challenges are to be met.

摘要

明确现有证据基础对于提高输血实践的有效性至关重要。英国系统评价倡议主要通过撰写关于输血医学重要主题的系统评价来实现这一目标。在此,我们描述过去5年的进展。我们是唯一为Cochrane对照试验中央登记册识别输血医学随机对照试验(RCT)的研究小组,迄今为止,我们已贡献了3002条RCT引文。本文考虑了未来的挑战,包括输血医学界需要更广泛地参与系统评价的维护和更新过程,以及确定进一步临床研究(包括临床试验)的主题并确定其优先级。如果要应对这些挑战,国际和本地研究小组之间的合作很重要。

相似文献

1
Improving the evidence base for transfusion medicine: the work of the UK systematic review initiative.完善输血医学的证据基础:英国系统评价倡议的工作
Transfus Med. 2009 Apr;19(2):59-65. doi: 10.1111/j.1365-3148.2009.00910.x. Epub 2009 Mar 23.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review.评估指定随机对照试验目标差值的方法:DELTA(试验中差值确定)综述。
Health Technol Assess. 2014 May;18(28):v-vi, 1-175. doi: 10.3310/hta18280.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.儿童镰状细胞病的一级卒中预防的临床效果和成本效益:系统评价和经济评估。
Health Technol Assess. 2012;16(43):1-129. doi: 10.3310/hta16430.
6
The impact of Cochrane Reviews: a mixed-methods evaluation of outputs from Cochrane Review Groups supported by the National Institute for Health Research.Cochrane系统评价的影响:对由英国国家卫生研究院支持的Cochrane系统评价小组产出的混合方法评估
Health Technol Assess. 2015 Apr;19(28):1-99, v-vi. doi: 10.3310/hta19280.
7
Where are the systematic reviews in transfusion medicine? A study of the transfusion evidence base.输血医学中的系统评价在哪里?输血证据基础研究。
Transfus Med Rev. 2010 Oct;24(4):286-94. doi: 10.1016/j.tmrv.2010.05.003.
8
Celebrating 20 years of evidence from the Cochrane Collaboration: what has been the impact of systematic reviews on nephrology?庆祝 Cochrane 协作组织成立 20 周年:系统评价对肾脏病学有何影响?
Nephrol Dial Transplant. 2015 Jun;30(6):871-7. doi: 10.1093/ndt/gfu232. Epub 2014 Jul 12.
9
Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians.旨在改善卫生系统管理人员、政策制定者和临床医生在决策过程中对系统评价的使用情况的干预措施。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009401. doi: 10.1002/14651858.CD009401.pub2.
10
The Cochrane tobacco addiction group.考科蓝烟草依赖工作组。
J Evid Based Med. 2013 Nov;6(4):213-5. doi: 10.1111/jebm.12065.